This cell line was selected because previous reports demonstrated that implants of these cells retain numerous characteristics frequently observed in human GBM tumors [33], including necrosis, regions of hypoxia, increased vascular endothelial growth factor (VEGF), HIF-1α expression and tumor invasiveness [33-37]. This evidence concerns the gene HIF1A and glioblastoma.